Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Fig. 6

Association of adiposity markers with prostate, testicular cancer in men and breast cancer (overall, pre and post menopausal) incidence. Penalised splines were used to present the association between adiposity markers and cancer outcomes. The adiposity markers were sex-standardised to 1-SD increment. Analyses were adjusted for age, sex and ethnicity, education, deprivation, smoking, dietary intake (alcohol, fruits and vegetables, red and processed meat, and oily fish), physical activity and sedentary behaviour. BMI, body mass index; BF%, body fat percentage; WHR, waist-hip ratio; WHtR, waist-height ratio; HC, hip circumference; HR, hazard ratio. Shaded areas represent 95% confidence intervals. All P values were corrected for multiple testing by using the Holm’s method. Participants classified as underweight (BMI < 18.5 kg/m2 were excluded from the analyses (n = 2629)

Back to article page